Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Drug Utilization Research
Drug Utilization Research
Type here to filter the list
(001) Exploratory Analysis of Patient Characteristics and Treatment Duration in Patients using Esketamine for Treatment-Resistant Depression: A Large Longitudinal Study Linking Commercial Claims Data to Electronic Medical Records
Favorite
(002) Assessing The Impact of the Slow-Release Oral Morphine Drug Shortages in Ontario: a Population-Based Time Series Analysis
Favorite
(003) Survival and drug treatment patterns in multiple myeloma patients exposed to an anti-CD38 monoclonal antibody, a proteasome inhibitor and an immunomodulatory imide drugs
Favorite
(004) Association of Medication Safety Announcements with topical calcineurin inhibitor Prescribing: A repeated cross-sectional analysis
Favorite
(005) Low-Value Prescriptions For Injury Hospitalisations: A Cohort Study
Favorite
(006) Spontaneous reporting of urinary dysfunction associated with polypharmacy: a case/non-case study
Favorite
(007) Prescription Ranitidine Use and Population Exposure in Six Canadian Provinces, 1996 to 2019
Favorite
(008) Association between physician characteristics and antiplatelet medication dispensed to community dwelling New Brunswick older adults following hospital discharge for myocardial infarction between 2009 and 2017
Favorite
(009) Extent of the Ranitidine Shortage and its Impact on Acid Suppression Drug Utilization in Canada and the United States: an Interrupted Time Series Analysis
Favorite
(010) Impacts of Tier-3 drug shortages on utilization trends across Canada: A cross-sectional analysis of 3 drug shortages
Favorite
(011) Assessment of Buprenorphine Dispensing in Texas Following the 2016 Federal-Level Buprenorphine Access Expansion Policies
Favorite
(012) Medical Use and Combination Drug Therapy Among US Adult Users Of Central Nervous System Stimulants: A Cross-Sectional Analysis
Favorite
(013) The impact of lidocaine prescribing reduction strategies: a comparison of two national health services in Europe
Favorite
(014) Use of intra-articular corticosteroid injections among osteoarthritis patients in UK general practice
Favorite
(015) Publicly funded access to prescription medicines in Brazil from 1998 to 2019
Favorite
(017) Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents
Favorite
(018) Primary Care Prescribing of Cardiovascular System Medications (England, 2015-2019): Variation and Associations
Favorite
(019) Real World Evidence (RWE) Couture: attributes of well-fitting regulatory grade evidence for efficacy decision making
Favorite
(020) Gender differences in anticancer drugs among patients with Non-Small Cell Lung Cancer in Taiwan
Favorite
(021) Characteristics of Prescription Drug Fills Using Pharmacy-Pharmacy Benefits Manager (PBM) Discount Programs: The "Goodrx" Model
Favorite
(022) Assessment of Narrow therapeutic Index Drugs and Associated Drug Related Problems: A Prospective Cohort Study
Favorite
(023) Validity of the ISMP Medication Safety Self-Assessment® for Long-Term Care tool in Australian nursing homes
Favorite
(024) Alopecia Areata Severity and Real-World Treatment Patterns
Favorite
(025) Monitoring biological treatments for psoriasis in the Brazilian Public Health System: a real-world study
Favorite
(027) Publicly funded prescription drugs dispensed to community dwelling New Brunswick older adults following hospital discharge for myocardial infarction between 2009 and 2017
Favorite
(028) Assessment of High-Risk Medications Utilization and Prescribing Patterns among Special Populations using WHO Prescribing Indicators
Favorite
(029) Early retirement pensioners diagnosed with mental and behavioral disorders caused by psychoactive substances (ICD F11-19 block) in Germany - characterization and utilization of medical rehabilitation
Favorite
(030) Gender differences in pattern of medication use in the population of Tuscany region, Italy, in 2021
Favorite
(032) Drug Utilization Evaluation of Narrow Therapeutic Index Drugs in A Tertiary Care Teaching Hospital
Favorite
(033) Pharmacists’ Perspectives on Facilitators and Barriers to Pharmacist Prescribing for Patients admitted to Hospital within Nova Scotia Health
Favorite
(034) Trends in Anti-Obesity Drugs Utilization, Spending, and Prices in Medicaid Programs: 1999–2021
Favorite
(035) Best practice implementation project on handwritten prescription practices in a public hospital in Uasin Gishu County, Kenya
Favorite
(036) Efficacy of restricted prescribing protocol of sacubitril valsartan in Heart Failure with reduced Ejection Fraction (HFrEF) in a tertiary center in Saudi Arabia
Favorite
(037) Clinical Characteristics of Patients Prescribed with Dapagliflozin in a Tertiary Care Teaching Hospital in India
Favorite
(038) A cross-national comparison between Denmark and the US on age-stratified psychotropic trends among youths: 2010-2020
Favorite
(039) Describing medication changes near end-of-life: Applied example and methodological considerations
Favorite
(040) Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries with Heart Failure
Favorite
(041) Factors associated with opioid overdose and dependence: retrospective cohort study with 959,286 patients initiating opioid therapy
Favorite
(042) The Size Paradox: Comprehensive Data and Better Methods Can Yield Significant Results with Smaller Sample Sizes in Real World Data (Size Doesn’t Always Matter)
Favorite
(043) Association of Recreational and Medical Cannabis Legalization with Opioid Prescribing and Mortality: A Generalized Difference-In-Difference Analysis
Favorite
(044) Assigning Defined Daily Doses (DDD) to Anatomical-Therapeutical-Chemical (ATC) codes that were not addressed by the World Health Organization (WHO): the example of antineoplastics and immunomodulating agents
Favorite
(045) The Impact of the 2016 CDC Guidelines on Opioid Prescribing in Chronic Low Back Pain: An Interrupted Times Series Analysis
Favorite
(046) An evaluation of commonly available imputation methods useful for RWE research
Favorite
(047) Complementary and integrative health modalities to prevent utilization of allopathic medications for dysmenorrhea: A prospective interventional study
Favorite
(048) Antidepressant Adherence Trajectories Before Tamoxifen Initiation and Risk of Subsequent Antidepressant Discontinuation Among US Women with Breast Cancer
Favorite
(049) Investigating the ability to adhere to cardiometabolic medication properties: a retrospective cohort study
Favorite
(050) Real-world management and outcomes for newly diagnosed AML patients initiating Venetoclax and hypomethylating agents in US community practice
Favorite
(051) Utilization of antidepressants in patients with chronic kidney disease: A nationwide cohort study
Favorite
(052) Assessment of medication adherence and its factors influencing poor medication adherence among psoriasis patients: a cross-sectional study
Favorite
(053) Blood Pressure Action Sheet and Medication Adherence for Hypertension: A mixed-method study in Yogyakarta, Indonesia
Favorite
(054) Closing the Gap on Inflammatory Bowel Disease Treatments and the Risk of Cancer: an International Collaboration Combining National Registries with Medical Chart Abstraction
Favorite
(055) Defining Key Deprescribing Measures From Electronic Health Data: Learnings From A Multisite Data Harmonization Project
Favorite
(056) Drug Utilization of Biologic Therapy for Inflammatory Bowel Disease Using Data of An Brazilian Healthcare Administrative Database (2008-2021)
Favorite
(057) Trajectories and predictors of prescription opioid tapering: a retrospective cohort study in Australian primary care
Favorite
(058) Dosing of cannabinoids associated with an opioid-sparing effect: A systematic review of longitudinal studies
Favorite
(059) Predictors of nonadherence to antihypertensives among adult initiating cancer treatment
Favorite
(060) The predictors of exposure to three-drug combinations among older adults in emergency department settings in the US
Favorite
(061) Psychiatric Prescription Drug Utilization and Related Overdoses Among Commercially Insured Individuals in the United States, 2020
Favorite
(062) Acne Vulgaris: Disease Severity and Real-World Treatment Patterns
Favorite
(063) The quality, supply chain, and use of uterotonics in the zone of influence in the Northern region of Ghana – a survey from healthcare providers’ perspective
Favorite
(064) Exposure to actionable pharmacogenomic medications in a nationally representative insurance claims database
Favorite
(065) A comprehensive overview of dispensing durations for all drugs applicable in pharmacoepidemiological studies using Danish data
Favorite
(066) Utility of Procedure Codes in Identifying Use of Long-Acting Cabotegravir in Administrative Claims Data
Favorite
(067) Exposure Patterns of Immune Checkpoint Inhibitors Among Older Medicare Beneficiaries with Non-Small Cell Lung Cancer
Favorite
(068) Clinical and Humanistic Impact of Clinical Pharmacist-Initiated Medication Information Services in Psychiatric Patients
Favorite
(069) Conceptual bases for the standardization of calculation approaches for establishing exposure duration of single drug utilization records in multi-database studies
Favorite
(070) Evaluation of critical care clinical pharmacist services and Predictors in identifying the medication related problems in critically ill patients in South India- A hospital based interventional study
Favorite
(071) Determination of Pill-Burden and Its Association with Treatment Burden among Patients with Advanced Stages of Chronic Kidney Disease in Qatar
Favorite
(072) To Analyze the Utilization Pattern of Antidotes in Poisoned Patients in a Tertiary Care Hospital
Favorite
(073) Adherence to statins and LDL-cholesterol control: a population-based study using primary care data
Favorite
(074) Community Pharmacists Knowledge, Attitude, and Practice towards Hypertensive Patient Counseling in the United Arab Emirates
Favorite
(076) Pharmacist knowledge, attitudes, practice and barriers towards providing health screening services in the community pharmacy
Favorite
(077) Antipsychotic-Induced Metabolic Syndrome - A Review
Favorite
(078) A cross-sectional online survey on ivermectin use for prevention and treatment of SARS-CoV-2 infection in a peruvian population
Favorite
(080) Frequency of potential drug-drug interactions among patients with acute clinical conditions visiting ambulatory patient education center of a tertiary care hospital
Favorite
(081) Real-World Survival Effectiveness of Edaravone in Amyotrophic Lateral Sclerosis: A Propensity Score Weighted, Registry-based, Canada-wide Cohort Study
Favorite
(082) The Utilization Pattern of Glucagon-Like Peptide-1 Receptor Agonist, Dipeptidyl Peptidase-4 Inhibitor, and Sodium Glucose Co-Transporter-2 Inhibitors in Type 2 Diabetes Mellitus in a Tertiary Care Hospital- A Retrospective Study
Favorite
(083) Trends and Disparities in Access to Oral Childhood Cancer Medicines in High Income and Low and Middle Income Countries, 2015-2020
Favorite
(084) Treatment Initiation, Time-to-Treatment, Treatment Duration and Treatment Discontinuation of Direct-Acting Antivirals for Hepatitis-C in Manitoba
Favorite
(085) Long-term use of prescription opioids and mortality: a population based, propensity-weighted cohort study with 767,299 patients initiating therapy
Favorite
(086) Data Cleaning to Estimate Dosing Frequency of Zoledronic Acid
Favorite
(087) A Systematic Review of Real-World Treatment Discontinuation of Interferon-free Direct-acting Antivirals in Patients with Hepatitis-C virus
Favorite
(088) Assessment of medication adherence among patients with acute clinical conditions in a tertiary care hospital
Favorite
(089) Prescription analysis emphasizing on medication adherence of antibiotics for lower respiratory tract infection
Favorite
(090) Use of Very Low-Dose Vaginal Estrogens Among Postmenopausal Women in the US
Favorite
(091) Association between the use of different classes of blood pressure-lowering drugs and risk of incident dementia: a multi-database cohort study
Favorite
(093) Adherence patterns one year after initiation of Sodium-glucose cotransporter 2 inhibitors: a national cohort study
Favorite
(094) Plans Change: A Competing Risks Analysis of Time to Unplanned Stopping of Long-Term Outpatient Antibiotic Treatment, 2015-2022
Favorite
